Begin main content

Drug Therapies for Immunosuppression in Adult Patients Following Islet Cell

Published on: March 14, 2013
Project Number: RB0575-000
Product Line: Rapid Response
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of common drug therapies for immunosuppression in adult patients following islet cell transplantation for the treatment of diabetes?
  2. What is the cost-effectiveness of common drug therapies for immunosuppression in adult patients following islet cell transplantation for the treatment of diabetes?

Key Message

Seven non-randomized studies were identified regarding the clinical effectiveness of common drug therapies for immunosuppression in adult patients following islet cell transplantation for the treatment of diabetes. No relevant cost studies were identified.

Tags

immunosuppressants, diabetes mellitus, glucocorticoids, immunosuppressive agents, islets of langerhans transplantation, sirolimus, tacrolimus, diabetes, mycophenolate mofetil, islets, Diabetics, Diabetic, Tacrolimusmycophenolate mofetil